Loading
We have very little insider data for 株式会社ノヴァックス so far: the most recent filing dates from 10 August 2022. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
5 of 5 declarations
株式会社ノヴァックス is a Japanese company specializing in the healthcare and pharmaceutical sector. It is listed on the XTKS market.